GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Izotropic Corp (XCNQ:IZO) » Definitions » Total Liabilities

Izotropic (XCNQ:IZO) Total Liabilities : C$5.16 Mil (As of Jan. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Izotropic Total Liabilities?

Izotropic's Total Liabilities for the quarter that ended in Jan. 2025 was C$5.16 Mil.

Izotropic's quarterly Total Liabilities increased from Jul. 2024 (C$4.56 Mil) to Oct. 2024 (C$4.79 Mil) and increased from Oct. 2024 (C$4.79 Mil) to Jan. 2025 (C$5.16 Mil).

Izotropic's annual Total Liabilities increased from Apr. 2022 (C$2.64 Mil) to Apr. 2023 (C$3.52 Mil) and increased from Apr. 2023 (C$3.52 Mil) to Apr. 2024 (C$4.08 Mil).


Izotropic Total Liabilities Historical Data

The historical data trend for Izotropic's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Izotropic Total Liabilities Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Total Liabilities
Get a 7-Day Free Trial 0.07 0.17 2.64 3.52 4.08

Izotropic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.19 4.08 4.56 4.79 5.16

Izotropic Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Izotropic's Total Liabilities for the fiscal year that ended in Apr. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.063+(0.015+0.001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.08

Total Liabilities=Total Assets (A: Apr. 2024 )-Total Equity (A: Apr. 2024 )
=0.232--3.846
=4.08

Izotropic's Total Liabilities for the quarter that ended in Jan. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.161+(0.004+-0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.16

Total Liabilities=Total Assets (Q: Jan. 2025 )-Total Equity (Q: Jan. 2025 )
=0.382--4.782
=5.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Izotropic Total Liabilities Related Terms

Thank you for viewing the detailed overview of Izotropic's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Izotropic Business Description

Traded in Other Exchanges
Address
800 - 15355, 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. The Izotropic Breast CT Imaging System, IZOview produces high-resolution breast images in 3D. The company has a worldwide license from the University of California to commercialize the technology.
Executives
Robert Louis Thast 10% Security Holder, Director, Senior Officer
Ali Reza Sodagar Director

Izotropic Headlines

No Headlines